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Abstract  
 
Clinical reports after traumatic brain injury (TBI) suggest frequent difficulties with sustained attention, but their objective 
measurement has proved difficult. In 1997, Robertson and colleagues reported on a new sustained attention assessment tool, the 
sustained attention to response task (SART). Individuals with TBI were reported to produce more errors of commission on the 
SART than control participants, and both groups showed a relationship between SART errors and everyday lapses of attention as 
measured by the cognitive failures questionnaire (CFQ). Although few direct replications of these findings have been reported, the 
SART has been used widely as a measure of sustained attention in TBI, in normal controls, and in various other clinical samples. 
  
As part of a program of research on attention in TBI, we administered the SART and the CFQ to a sample of 34 survivors of 
moderate to severe TBI and to 35 control participants. CFQ scores reported by significant others showed clear group differences 
in everyday lapses of attention. Despite this, group differences in SART errors of commission were small and non-significant, and 
the correlations between SART errors and CFQ scores were small within both groups. Further analyses excluding participants 
with invalid score profiles, or restricting the analysis to the first performance of the SART failed to alter the results.  
 
These findings suggest that more research is needed to establish the validity of the SART as a measure of sustained attention 
after TBI, and to determine under what circumstances the original findings hold.    
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1. Introduction  
 
   Attention deficits are common after traumatic brain injury (TBI), (Dikmen, Machamer, Winn, & Temkin, 
1995; Jacobs, 1988; McKinlay, Brooks, Bond, Martinage, & Marshall, 1981) but their objective 
measurement has proved challenging. Difficulties with sustained attention, in particular, are frequently noted 
clinically, and a number of studies have attempted to measure this deficit using traditional vigilance tasks, in 
which a subject detects (typically) infrequent targets over several minutes’ time (Parasuraman, 1984). In 
such tasks, the slope of either reaction time (slowing) or accuracy (declining) over time may be steeper after 
TBI, (Melamed, Rahamani, Greenstein, Groswasser, & Najenson, 1985; Whyte, Polansky, Fleming, Coslett, 
& Cavallucci, 1995) but this finding has not been consistent (Brouwer & van Wolffelaar, 1985; Buchtel, 
1987). 
 
  In 1997, Robertson and colleagues reported on a new sustained attention measure—the “sustained attention 
to response task” (SART), (Robertson, Manly, Andrade, Baddeley, & Yiend, 1997) which differs from 
typical vigilance tasks in being fairly short (4.3 min), and in requiring very frequent responses (89% of 
trials) and rare withholding of responses. In brief, this task involves the presentation of 225 digits at the 
center of a computer screen in random order, with an ISI of 1150 ms. The subject’s task is to press a 
response key as quickly as possible in response to every digit except “3.” Robertson and colleagues argue 
that withholding responses to the infrequent non-targets requires controlled (i.e., attention-demanding) 
processing, to combat the tendency to automatize responding to the more frequent targets. Errors of 
commission (i.e., responding to “3” stimuli) are thought to be due to lapses of attention, reflecting an 
impairment of sustained attention.  
 
  The authors of the SART make two key claims to support its validity as a measure of sustained attention in 
TBI:  
1. Scores on the SART differ significantly between individuals with TBI and control subjects, with the 
TBI subjects making more errors of commission.  
 
2. SART errors of commission are correlated, in both normal control subjects and those with TBI, with 
scores provided by significant others on the Cognitive Failures Questionnaire (CFQ), (Broadbent, 
Cooper, FitzGerald, & Parkes, 1982)a measure of everyday “lapses of attention.”  
 
The first claim is important if this task is argued to be sensitive to a clinically salient deficit that is 
prevalent in TBI but not in controls. The second claim is important to support the clinical and ecological 
validity of this task as a measure specifically of lapses in attention that can be seen in everyday life.  
 
A number of studies have used the SART as a measure of sustained attention in TBI, (Chan, 2001; Chan, 
2002; Chan, Hoosain, Lee, Fan, & Fong, 2003; Dockree et al., 2004) and in other subject groups (Dale, 
Naik, & Thompson, 2003; David et al., 2002; Farrin, Hull, Unwin, Wykes, & David, 2003; Hull et al., 2003; 
Manly, Lewis, Robertson, Watson, & Datta, 2002; Manly, Robertson, Galloway, & Hawkins, 1999; 
Thompson, Rushman, Fox, Lloyd, & Atcheson, 2002; Wallace, Kass, & Stanny, 2001 ), and have studied 
the PET correlates of this task (Manly et al., 2003). A more recent, fixed-order variation on the task (SART-
Fixed), is reported to produce fewer errors of commission by both TBI and control subjects, but with less 
overlap in the error rates of the two groups (Manly et al., 2003). Despite the interest in and dissemination of 
the original SART task, replications of the key original findings have been few.  
 
As noted in Table 1, of the studies that compared errors of commission between individuals with TBI and 
control participants, one clearly replicated the group difference reported by Robertson and colleagues, 
(Manly et al., 2003) while another did not, (Chan, 2001) although TBI participants in this latter study had 
mild injuries. Two other studies produced equivocal results (Chan, 2002; Chan et al., 2003; Dockree et al., 
2004).  
 
We identified only two studies that examined the relationship between SART errors of commission and 
everyday lapses of attention as measured by the CFQ, in individuals with TBI, normal control participants, 
or both. In a study by Manly and colleagues, participants split into high and low CFQ score groups differed 
in their SART errors of commission (Manly et al., 1999). Wallace et al., however, found no correlation 
between self-reported CFQ scores and SART errors of commission in a group of university students 
(Wallace et al., 2001). Therefore, we attempted to replicate the original findings of Robertson et al.  
 
2. Methods  
2.1. Study participants  
Participants with TBI whose data are reported here were involved in a larger study on methylphenidate 
and attention (Alban, Hopson, Ly, & Whyte, 2004; Whyte et al., 2004). Data from control participants have 
not been previously reported. In brief, participants between the ages 16 and 60 with a history of moderate or 
severe non-penetrating TBI at least 3 months prior to testing were recruited from a variety of clinical sources 
and research registries. Severity was defined by a Glasgow Coma Scale (GCS) score less than 12 (generally 
recorded in the Emergency Department), prospectively documented post-traumatic amnesia (PTA) of 
greater than 1 h, and/or focal abnormality on a neuroimaging study. A subjective complaint of attention 
difficulties by the participant, treating clinician, or caregiver was also required. Participants received no 
structured treatment of these attention complaints during the study period, other than the study drug. 
Potential participants were excluded for pre-injury neurologic disease, psychosis, major affective disorder, 
mental retardation, or attention deficit hyperactivity disorder, current abuse of alcohol or recreational drugs, 
or cumulative use of these substances judged sufficient to contribute independently to cognitive impairment. 
Those taking psychoactive medications other than anti-convulsants were also excluded. Control participants 
who had never sustained a traumatic injury resulting in unconsciousness were recruited from hospital staff, 
social contacts of the participants with TBI, and through public advertising. The same exclusion criteria 
were applied. TBI and control participants were well matched for demographics and estimated premorbid 
IQ, as shown in Table 2.  
2.2. Procedure  
SART data were collected weekly at the same time of day, for 2 weeks (controls) or 6 weeks (participants 
with TBI), as part of a much larger data acquisition effort involving multiple other tasks (Whyte et al., 
2004). The SART was administered via a Macintosh computer, programmed with Psyscope, and modified to 
record the responses with a button box for more precise RT timing. The task lasted under 5 min. Those with 
TBI received methylphenidate (M) or placebo (P) in alternating 6-day epochs (counterbalanced for 
MPMPMP and PMPMPM orders) with one washout day in between. Controls received no medication. A 
significant other also provided weekly CFQ (Broadbent et al., 1982) ratings on each participant. The CFQ 
assesses the frequency of everyday lapses in attention using a five point Likert type scale, ranging from very 
often to never, with higher scores indicating more difficulties. For participants with TBI, only the SART and 
CFQ scores from placebo weeks were used in the analyses.  
 
2.3. Data analysis  
Comparability of participants with and without TBI was assessed using χ
2 
tests for categorical and T-tests 
for continuous variables. Histograms of SART RT data for each participant, collapsed across the two 
(controls) or three (placebo sessions of individuals with TBI) sessions revealed the expected skewed-to-the-
right RT distributions in all control participants and most participants with TBI. In some participants with 
TBI, however, the right side of the distribution stopped abruptly at 1150 ms (the ISI), rather than tailing off, 
indicating a proportion of late responses that were recorded as omissions on the trial in question and 
premature responses on the subsequent trial, thus invalidating both RT and accuracy. Representative 
distributions are shown in Fig. 1. A decision rule was used to eliminate these “invalid” participants from 
subsequent analyses.
1  
In this report, we focus on those with valid data (n = 26), but also display to results 
for the whole sample (n = 34), to allow comparison with other investigators that may not have excluded such 
individuals.  
Performance on the SART was assessed by the number of commission and omission errors. These error 
rates and CFQ scores were averaged over the three placebo sessions for each participant with TBI, and over 
the two testing sessions for controls. Additional analyses, based on only the first session of data for each 
subject, were also done to explore the confounding effects of practice and possible drug carry over effects. T 
tests were used to investigate group differences in error rates and CFQ scores. Paired T tests were used to 
assess changes in performance from session to session. Pearson correlations were used to compare the 
relationships between the SART variables and CFQ scores within groups.
2 
Effect sizes (Cohen’s d) were 
also calculated to facilitate comparison of results between our study and others’ differing in sample size 
(Cohen, 1988).  
 
3. Results  
Because this study was not originally designed to replicate the SART findings, we are aware of the 
possible confounding effects of repeated practice and drug carry over effects, inherent in our study design 
that might have differentially affected the two groups. Below we report first on the data analysis that makes 
use of all the valid data from both groups. However, we follow this with an analysis that seeks to eliminate 
the possible influence of these confounds.  
 
There was no significant group difference in errors of commission or errors of omission when this analysis 
was performed using all of the sessions of those with valid data, and the effect size for group with respect to 
errors of commission was zero, as shown in Table 3. As expected, RT was significantly slower in those with 
TBI, despite elimination of the most impaired individuals. CFQ scores differed significantly between 
groups, with a moderate to large effect size; those with TBI were reported to have more attentional lapses. 
The correlation between CFQ scores and SART errors of commission did not approach significance in either 
group, as shown in Table 3.  
 
   A comparison of the full sample of TBI participants (including those with invalid profiles) with controls 
yielded similar findings with the exception of significantly greater errors of omission in those with TBI, as 
might be expected from the data recording error we identified. CFQ and RT differences between groups 
were even more dramatic, as expected from including more severely impaired participants. However, errors 
of commission again showed no significant group differences, and the relationship between errors of 
commission and CFQ scores remained negligible.  
 
_______________________________________________________________________________________ 
  1 Details of the rule for excluding invalid subjects are available from the authors. In brief, histograms grouped by visual 
inspection were used to identify a proportion of trials with RTs > 1000 ms which produced the same grouping. Those excluded 
had more severe current disability levels as measured by the disability rating scale, and has slower RTs on a range of other 
assessment tasks not reported here. No control subjects demonstrated an invalid profile. 
 
   2 Analysis were replicated with nonparametric methods, but did not alter the findings. 
 
   As noted above, these analyses were conducted on performance scores averaged over two (controls) or 
three (participants with TBI) sessions, whereas prior studies have generally been based on a single 
administration of both SART and CFQ. Analysis of changes in errors of commission with practice showed a 
significant reduction from session 1 to session 2 among controls (mean of 6.37 versus 5.03, P < 0.01), and 
from session 1 to session 3 in patients (session 2 for these individuals was on methylphenidate) (mean of 7.3 
versus 5.1, P < 0.01). To control both for these practice effects
3 
and for the possibility of carryover effects of 
the study drug, we repeated the analyses using only the true first data collection session for both subject 
groups. Since the first session was conducted on methylphenidate for half of the participants with TBI, the 
valid TBI sample for this analysis was reduced by half (to 13). This sample of 13 had not yet been exposed 
to methylphenidate, removing persistent residual treatment effects as a potential confound. 
 
The remaining participants with TBI remained demographically similar to controls (See Table 2). 
Because of the reduced sample, we focus here on effect sizes rather than p values. Differences in errors of 
commission remain small, although the effect size was slightly larger than when computed across all 
sessions (0.25 versus 0) (See Table 4). Group differences in errors of omission were also small. In contrast, 
differences in RT and CFQ between groups remained substantial (effect sizes of 0.84 and 0.52, respectively, 
quite comparable to the values from the averaged sessions). Correlations between SART errors of 
commission and CFQ scores remained small in both groups.  
 
4. Discussion  
Our research failed to replicate either of the key original findings by Robertson and colleagues—that 
individuals with TBI make more errors of commission on the SART than uninjured controls, and that the 
number of such errors in both groups is correlated with the severity of everyday lapses of attention, as 
measured by significant others’ reports on the CFQ. Errors of omission, which were not hypothesized to 
reflect a sustained attention deficit, differed between groups only when TBI participants with invalid data 
were included. Given the discrepancy between the original report and our attempted replication, it is 
important to consider study limitations and differences between our methods and those of Robertson and 
colleagues, that might potentially explain the different pattern of results.  
One possibility is that our study lacked sufficient statistical power to identify these patterns. This appears 
unlikely. For the assessment of a group difference in errors of commission, Robertson’s study involved 22 
individuals with TBI and 17 controls, in comparison to our sample of 26 (valid) individuals with TBI and 35 
controls. For the analysis of correlations between errors of commission and CFQ scores, Robertson used 
data from 21 individuals with TBI and 75 control participants, whereas we again used data from 25 
individuals with TBI and 32 controls. Moreover, our calculation of effect sizes and correlations suggests that 
the group difference in SART errors of commission (effect sizes 0–0.25 for the comparison of TBI 
participants with valid data and controls) and the amount of variance in CFQ scores explained by SART 
errors (correlations of 0.11–0.20 for individuals with TBI and −0.05 to −0.09 for control participants) are 
small in magnitude, not simply that we lacked statistical power. Moreover, histograms showing the rates of 
errors of commission in the two groups show substantial overlap (See Fig. 2).  
Another possible explanation of the discrepancy could be differences in our participants. That is, if our 
participants with TBI had milder injuries or had undergone more substantial recovery, they might differ less 
from controls, particularly since we excluded our most impaired participants because of invalid SART data. 
 
_____________________________________________________________________________________ 
   3 It is worth noting that Robertson et al attribute SART errors of commission to the development of automatic response 
tendencies, perhaps predicting that such errors might become more prevalent rather than less so with practice. 
However, our TBI participants do not appear to be less impaired than those of Robertson et al. Based on 
duration of post-traumatic amnesia, our sample contained 22/23 (>95%) participants with very severe or 
extremely severe injuries, compared to 16/32 (50%) in the Robertson study. It does appear, however, that 
our sample was more chronic (median time since injury nearly 3 years) than those studied by Robertson (9–
18 months), but certainly not fully recovered. Our TBI participants had continued disability, as measured by 
the DRS, as well as subjective complaints of attention deficits. In fact, our participants with TBI performed 
relatively similarly to those in Robertson’s study, while our control participants performed somewhat worse 
than theirs. In addition, our groups differed significantly in CFQ scores, suggesting that our participants with 
TBI did suffer from the clinical deficit that the SART is intending to measure. Moreover, differences in 
severity of injury or the nature of our control participants could explain the lack of a group difference in 
SART commission errors, but not the negligible relationship between SART errors and CFQ scores within 
each group. Since anxiety and depression have been shown previously to contribute to SART performance 
(Chan, 2002; Chan et al., 2003), it is possible that our samples differed from Robertson’s along these 
dimensions. We cannot, however, verify this, since neither our study nor theirs measured these emotional 
states.  
 
We analyzed our data both including and excluding participants with invalid SART data, to explore the 
possibility that Robertson’s findings might have been based, in part, on the inclusion of participants with 
undetected invalid data. However, as shown in Table 3, the inclusion of those individuals produced larger 
group differences in errors of omission, but not in errors of commission. We also assessed whether 
differences might be due to a drop in errors of commission during practice, since our participants performed 
the SART on multiple occasions. However, although practice effects were seen in SART performance, 
restriction of the analysis to the initial testing session did not substantially alter the results. Neither does the 
discrepancy appear to be attributable to drug carryover effects, since restricting the analysis to those whose 
initial session of data collection was conducted on placebo did not substantially alter the results. Moreover, 
the plasma half-life of methylphenidate is 1.5–2.5 h, making such carryover effects relatively unlikely 
(Challman & Lipsky, 2000). It remains possible, however, that patients’ SART performance even in the 
initial session was elevated by a placebo effect associated with mere participation in a drug study.  
 
Despite considering a number of differences in participants and methodology between our study and 
Robertson et al.’s, we were not able to identify a reason for the key differences in our findings. 
Nevertheless, since a number of researchers have adopted the SART as a measure of sustained attention, we 
believe it is important to report the differences in findings and to explore their source further, in order to 
more precisely define the circumstances under which the SART validly measures sustained attention. In 
addition, it is important for investigators using the SART, particularly with clinical populations, to be aware 
of the validity problem associated with slow responders, and to screen their RT distributions to ensure that 
such problems do not contaminate their results.  
 
After adopting the original SART for our research, the fixed SART was reported to produce lower rates of 
errors of commission, but improved discrimination between individuals with TBI and controls (Manly et al., 
2003). It has been reported that the fixed SART reduces reliance on inhibition of ongoing responses and 
more purely measures sustained attention (Bellgrove, Hawi, Kirley, Gill, & Robertson, 2005). Thus, it may 
be that results from the fixed SART can be replicated more reliably. Future research on both versions of the 
task should verify the group differences in error rates and their relationship to everyday errors of attention 
and clinically important deficits.  
5. Conclusion  
We were unable to replicate two key findings related to the original version of the SART—that errors of 
commission differ between individuals with moderate and severe TBI, and matched controls, and that SART 
commission error rates are correlated with everyday attention difficulties as measured by the CFQ. Although 
the reason for the difference in results between our laboratory that of Robertson et al is elusive, additional 
research should be done on the SART and/or the newer fixed SART to further define its validity in both 
respects.  
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Table 1  
Key Studies on the SART  
Authors Subjects Procedure Results Support for 
TBI/control difference 
in SART 
Support for 
relationship between 
SART and CFQ 
Manley et al. 
(1999) 
 
 
 
 
 
Manley et al. 
(2003) 
 
 
 
Chan (2002, 
Chan et al. 
(2003) 
 
 
 
Wallace and 
Vodanovich 
(2003) 
 
 
Chan (2001) 
 
 
Dockree et al. 
(2004) 
 
 
 
 
Farrin et al. 
(2003) 
 
 
60 Controls 
 
 
 
 
 
 
19 Individuals with TBI 
(mostly severe), Random 
and fixed SART 16 
controls 
 
Individuals with “TBI” 
(>80% had no Random 
SART and several al. 
(2003) PTA, >60% had 
no LOC) other tasks 
 
151 University students 
 
 
 
 
30 Individuals with mild 
TBI, 68 controls 
 
10 Individuals with TBI 
(mostly severe), 10 
controls 
 
 
 
102 British soldiers 
w/and w/o depression 
 
Ss divided into two 
groups based on CFQ 
scores; SART and 
other go/no-go tasks 
w/different target 
frequency done 
 
Random and fixed 
SART 
 
 
 
Random SART and 
several other tasks 
 
 
 
 
Random SART and 
CFQ 
 
 
 
Random SART 
 
 
18 min version of 
Random SART, CFQ 
 
 
 
 
Random SART, CFQ 
Low CFQ group made more errors of 
commission than high CFQ group, but only in 
the SART 
 
 
 
 
TBI Ss made more errors of commission on 
both tasks than controls; both groups made 
fewer errors on fixed SART; TBI Ss also made 
more errors of omission 
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 Table 2 
Characteristics of participants 
 
  
 Controls         Patients with valid data                p  p 
  
Patients with valid data for 
first true placebo session   
n  35                   26  13   
Demographic characteristics     
   Age (years)     
        Mean  37                   36                                             0.78  37  0.91 
        Range  17–55             20–55  24–55   
   Sex, n (%)                                                                          0.75   0.92 
        Male  30 (86)            23 (88)  11 (85)   
        Female  5 (14)              3 (12)  2 (15)   
   Ethnicity, n (%)                                                                          0.63   0.44 
        White  21 (60)            18 (69)  10 (77)   
        African American  12 (34)            6 (23)  2 (15)   
        Hispanic  2 (6)                2 (8)  1 (8)   
   Education (years)     
        Mean  12.5                 13                                             0.45   0.58 
        Median  12                    12    
        Range  8–17                10–18    
   Estimated IQ     
        NAART estimate (mean, S.D.)  101 (10.6)        98 (11.3)                                  0.26  99 (12.3)  0.66 
        Demographic regression formula  
 
101 (8.3)         103 (9.6)                                   0.41  103 (10.3)  0.54 
Injury and disability characteristics     
   Estimated duration of PTA     
        Mild  0  0   
        Moderate  1  1   
        Severe  0  0   
        Very severe  3  1   
        Extremely severe  19  10   
Time post injury     
        Range  3.6 months–34.2 years  3.6 months–34.2 years   
        Median  2.8 years  3.9 years   
 
 
 
Table 3 
Scores averaged across all sessions 
 
 
 
Descriptive statistics 
 
TBI participants-valid data 
 
All TBI participants 
 
Uninjured control participants 
 n Mean Range S.D. Effect 
size 
pa n Mean Range S.D. Effect 
size 
pa n Mean Range S.D. 
SART commission 26 5.7 0-15.7 4.5 0 0.99 34 6.8 0-17.3 4.8 0.28 0.27 35 5.7 2-11.5 3.1 
SART omission 26 4.5 0-22.7 5.2 0.08 0.75 34 12.8 0-77.7 18.5 0.64 0.01 35 4 0-32 7.3 
SARTRT 26 432 283-616 78 0.83 0.002 34 465 283-643 94 1.14 <.001 35 370 245-541 74 
CFQ 
 
25 11.1 0-22 6.2 0.62 0.03 32 12 0-22 6 0.78 0.003 31 7.6 .5-23.5 5.1 
Correlations TBI participants-valid data All TBI participants Uninjured control participants 
 n r - - - pb n r - - - pb n r - pb 
CFQ v. SART commission 25 0.11    0.61 32 0.18    0.32 31 -0.09  0.64 
CFQ v. SART omission 25 0.09    0.68 32 0.19    0.3 31 -0.31  0.09 
    
a p Value of the difference with control participants. 
    
  b Within-group p value for the correlation. 
 
 
 
Table 4  
Data from first session only  
 
  
 
Descriptive statistics 
 
TBI participants-valid data 
 
Uninjured control participants 
 n Mean Range S.D. Effect 
size 
pa n Mean Range S.D. 
SART commission 13 7.4 2-16 4.5 0.25 0.48 35 6.4 1-16 4 
SART omission 13 5.1 0-13 5.2 0.09 0.75 35 4.3 0-51 10.4 
SARTRT 43
5 
432 259-545 80.7 0.84 0.02 35 370 237-574 79.2 
CFQ 
 
12 11.2 1-24 6.7 0.52 0.18 31 8.1 0-25 5.5 
Correlations TBI participants-valid data 
 n r - - - pb n r - pb 
CFQ v. SART commission 12 0.2    0.54 31 -0.05  0.8 
CFQ v. SART omission 12 0.31    0.32 31 -0.27  0.14 
 
 
 
 
 
 
 
 
 
Fig. 1 
  
(A) Shows the distribution of RTs on correct trials, collapsed across two testing sessions for a representative control participant.  
(B) Shows a similar distribution across three testing session for a participant with TBI who was included in the analysis of participants with valid 
data. Although the distribution is shifted to the right compared to the control participant, the full distribution appears visible.  
(C) Shows a comparable distribution in a participant with TBI who was excluded from the analysis. Note that this individual’s RT distribution ends 
abruptly on the right.  
 
  
 
 
 
Fig. 2 
 
(A) Shows the distribution of average rates of commission errors (across 3 sessions for participants with TBI and 2 sessions for control 
participants). 
(B) Shows the distribution of commission errors in the first session for each group.  Considerable overlap can be seen between the two 
distributions. 
 
 
